Tuesday, February 10, 2026 | 02:52 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Orchid Pharma Ltd

Board Meeting Intimation for The Quarter-III Of Financial Year 2025-26 Ended On December 2025.

02:37 PM, 6th Feb 2026

Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 inter alia to consider and approve Unaudited Limited Reviewed Financial Results (Standalone & Consolidated) of the Company for the Quarter-III of Financial Year 2025-26 ended on December 31 2025.

More Orchid Pharma Ltd Announcements